BIOMAT Database Logo BIOMAT Database Logo

Fast neutron radiation therapy for glioblastoma multiforme. Results of an RTOG study. 1983

T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson

Between January 1977 and September 1980, 166 patients were entered on a RTOG protocol comparing neutron-boost radiotherapy with standard treatment for patients with glioblastomas. Eighty-three patients were randomized to receive a neutron boost and 83 to receive a photon boost after 50 Gy photon, whole-brain irradiation. Of these, six were ineligible and two were cancelled, leaving 158 patients available for analysis. The median survival for the neutron-boost group was 9.8 months, compared to 8.6 months for the photon-boost group. The difference is not statistically significant. Autopsies revealed actively growing persistent tumor in all photon-treated patients compared to no evidence of actively growing tumor in the majority of neutron-treated patients.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005214 Fast Neutrons Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts. Fast Neutron,Neutron, Fast,Neutrons, Fast
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
[Fast neutron therapy for glioblastoma multiforme (astrocytoma grade IV)].
January 1982, Gan no rinsho. Japan journal of cancer clinics,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Positron emission tomography-guided conformal fast neutron therapy for glioblastoma multiforme.
February 2008, Neuro-oncology,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Fast neutron beam radiotherapy of glioblastoma multiforme.
August 1976, AJR. American journal of roentgenology,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Fast neutron radiotherapy for locally advanced prostate cancer: results of an RTOG randomized study.
September 1985, International journal of radiation oncology, biology, physics,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Fast-neutron irradiation of glioblastoma multiforme. Neuropathological analysis.
July 1978, Journal of neurosurgery,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Boron neutron capture therapy for glioblastoma multiforme.
April 2005, Pharmacy world & science : PWS,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Interstitial 252Cf neutron therapy for glioblastoma multiforme.
December 1982, American journal of clinical oncology,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Fast neutron radiation therapy for unresectable squamous cell carcinomas of the head and neck: the results of a randomized RTOG study.
November 1985, International journal of radiation oncology, biology, physics,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme.
March 2008, Acta neurologica Scandinavica,
T W Griffin, and R Davis, and G Laramore, and F Hendrickson, and A Rodrigues-Antuñez, and D Hussey, and J Nelson
Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group.
June 1988, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!